icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Co-Formulated Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Chronic HCV Genotype 4 Infection Without Cirrhosis and With Compensated Cirrhosis in Egypt (AGATE-II)
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
 
Gamal Esmat1, Wahid Doss2, Roula B Qaqish3, Imam Waked4, Gamal Shiha5, Ayman Yosry2, Mohamed Hassany2, Jennifer King3, Carolyn Setze3, Rebecca Redman3, Niloufar Mobashery3
1Cairo University, Cairo, Egypt; 2National Hepatology & Tropical Medicine Research Insti tute, Cairo, Egypt; 3AbbVie Inc., North Chicago, Illinois, United States; 4National Liver Institute, Menoufiya, Egypt; 5Egyptian Liver Research Institute And Hospital (ELRIAH), Dakahliah, Egypt

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif